CryoLife resolves FDA’s warning letter issues

The U.S. Food and Drug Administration has resolved CryoLife Inc.’s warning letter issues from 2013. The Kennesaw, Ga.-based implantable biological medical device and cardiovascular tissue processing company said Monday it has “successfully implemented corrective actions put in place following the warning letter it received from the FDA.” The close-out letter follows a re-inspection in March 2015 by the FDA at CryoLife’s manufacturing facility and headquarters in Kennesaw. The FDA found…